Trial · NCT03813238
Outcomes29
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 20 of 29
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Change From Baseline in the Movement Disorder-Childhood Rating Scale (MD-CRS) Part II Total Score (Movement Disorder Severity, Centrally Read) at Week 15 | Baseline, Week 15 | The mITT analysis set included all randomized participants with at least 1 postbaseline centrally read MD-CRS part II assessment. | units on a scale | LEAST_SQUARES_MEAN |
| SECONDARY | Change From Baseline in the MD-CRS Part I Total Score (General Assessment, Centrally Read) at Week 15 | Baseline, Week 15 | The mITT analysis set included all randomized participants with at least 1 postbaseline centrally read MD-CRS part II assessment. | units on a scale | MEAN |
| SECONDARY | Caregiver Global Impression of Improvement (CaGI-I) Scale Score (Global, Caregiver Rated) at Week 15 | Week 15 | The mITT analysis set included all randomized participants with at least 1 postbaseline centrally read MD-CRS part II assessment. | units on a scale | MEAN |
| SECONDARY | Clinical Global Impression of Improvement (CGI-I) Scale Score (Global, Physician Rated) at Week 15 | Week 15 | The mITT analysis set included all randomized participants with at least 1 postbaseline centrally read MD-CRS part II assessment. | units on a scale | MEAN |
| SECONDARY | Change From Baseline in Unified Huntington's Disease Rating Scale-Total Maximal Chorea (UHDRS-TMC) Score (Centrally Read) at Week 15 | Baseline, Week 15 | The mITT analysis set included all randomized participants with at least 1 postbaseline centrally read MD-CRS part II assessment. | units on a scale | MEAN |
| SECONDARY | Change From Baseline in Unified Huntington's Disease Rating Scale-Total Maximal Dystonia (UHDRS-TMD) Score (Centrally Read) at Week 15 | Baseline, Week 15 | The mITT analysis set included all randomized participants with at least 1 postbaseline centrally read MD-CRS part II assessment. | units on a scale | MEAN |
| SECONDARY | Change From Baseline in the MD-CRS Part I Total Score (General Assessment, Physician Rated) at Week 15 | Baseline, Week 15 | The mITT analysis set included all randomized participants with at least 1 postbaseline centrally read MD-CRS part II assessment. Here, overall number of participants analyzed = participants evaluable for this outcome measure. | units on a scale | MEAN |
| SECONDARY | Change From Baseline in the MD-CRS Part II Total Score (General Assessment, Physician Rated) at Week 15 | Baseline, Week 15 | The mITT analysis set included all randomized participants with at least 1 postbaseline centrally read MD-CRS part II assessment. Here, overall number of participants analyzed = participants evaluable for this outcome measure. | units on a scale | MEAN |
| SECONDARY | Change From Baseline in MD-CRS Global Index Score (Calculated From MD-CRS Parts I and II Total Scores, Physician Rated) at Week 15 | Baseline, Week 15 | The mITT analysis set included all randomized participants with at least 1 postbaseline centrally read MD-CRS part II assessment. Here, overall number of participants analyzed = participants evaluable for this outcome measure. | units on a scale | MEAN |
| SECONDARY | Change From Baseline in MD-CRS Global Index Score (Calculated From MD-CRS Parts I and II Total Scores, Centrally Read) at Week 15 | Baseline, Week 15 | The mITT analysis set included all randomized participants with at least 1 postbaseline centrally read MD-CRS part II assessment. Here, overall number of participants analyzed = participants evaluable for this outcome measure. | units on a scale | MEAN |
| SECONDARY | Change From Baseline in UHDRS-TMS Score (Physician Rated) at Week 15 | Baseline, Week 15 | The mITT analysis set included all randomized participants with at least 1 postbaseline centrally read MD-CRS part II assessment. Here, overall number of participants analyzed = participants evaluable for this outcome measure. | units on a scale | MEAN |
| SECONDARY | Change From Baseline in UHDRS-TMC Score (Physician Rated) at Week 15 | Baseline, Week 15 | The mITT analysis set included all randomized participants with at least 1 postbaseline centrally read MD-CRS part II assessment. Here, overall number of participants analyzed = participants evaluable for this outcome measure. | units on a scale | MEAN |
| SECONDARY | Change From Baseline in UHDRS-TMD Score (Physician Rated) at Week 15 | Baseline, Week 15 | The mITT analysis set included all randomized participants with at least 1 postbaseline centrally read MD-CRS part II assessment. Here, overall number of participants analyzed = participants evaluable for this outcome measure. | units on a scale | MEAN |
| SECONDARY | Change From Baseline in Pediatric Evaluation Disability Inventory-Computer Adapted Test (PEDI-CAT) Score (Activities of Daily Living [ADL], Caregiver Completed, Content-Balanced Version) at Week 15 | Baseline, Week 15 | The mITT analysis set included all randomized participants with at least 1 postbaseline centrally read MD-CRS part II assessment. Here, overall number of participants analyzed = participants evaluable for this outcome measure. | units on a scale | MEAN |
| SECONDARY | Change From Baseline in the CP Module of the Pediatric Quality of Life Inventory (PedsQL) Total Score (Quality of Life [QoL], Participant/Caregiver) at Week 15 | Baseline, Week 15 | The mITT analysis set included all randomized participants with at least 1 postbaseline centrally read MD-CRS part II assessment. Here, overall number of participants analyzed = participants evaluable for this outcome measure. 'Number analyzed' = participants evaluable for specified category. | units on a scale | MEAN |
| SECONDARY | Patient Global Impression of Improvement (PGI-I) Scale Score (Global, Participant/Caregiver) at Week 15 | Week 15 | The mITT analysis set included all randomized participants with at least 1 postbaseline centrally read MD-CRS part II assessment. Here, overall number of participants analyzed = participants evaluable for this outcome measure. | units on a scale | MEAN |
| SECONDARY | Change From Baseline in Clinical Global Impression of Severity (CGI-S) Scale Score (Global, Physician Rated) at Week 15 | Baseline, Week 15 | The mITT analysis set included all randomized participants with at least 1 postbaseline centrally read MD-CRS part II assessment. Here, overall number of participants analyzed = participants evaluable for this outcome measure. | units on a scale | MEAN |
| SECONDARY | Number of Participants With CaGI-I Response | Week 15 | The mITT analysis set included all randomized participants with at least 1 postbaseline centrally read MD-CRS part II assessment. Here, overall number of participants analyzed = participants evaluable for this outcome measure. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Participants With CGI-I Response | Week 15 | The mITT analysis set included all randomized participants with at least 1 postbaseline centrally read MD-CRS part II assessment. Here, overall number of participants analyzed = participants evaluable for this outcome measure. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Participants With CGI-S Response | Week 15 | The mITT analysis set included all randomized participants with at least 1 postbaseline centrally read MD-CRS part II assessment. Here, overall number of participants analyzed = participants evaluable for this outcome measure. | Participants | COUNT_OF_PARTICIPANTS |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03813238/outcomes